Urology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cesaro S et al. - Cidofovir may be a potentially effective therapy for BKV-HC, but evidence supporting its use requires randomized controlled trials.

Related Articles

The relationship between sexual abuse and interstitial cystitis/painful bladder syndrome
Current Urology Reports, 11/13/09    Relevance Score: 87%

Risk factors for poor sleep quality among patients with interstitial cystitis in Taiwan
Neurourology and Urodynamics, 11/09/09    Relevance Score: 87%

Emphysematous Cystitis
Urology, 10/28/09    Relevance Score: 85%

Urodynamic testing and interstitial cystitis/painful bladder syndrome
International Urogynecology Journal, 10/21/09    Relevance Score: 84%

OmpA of uropathogenic Escherichia coli promotes post-invasion pathogenesis of cystitis
Infection and Immunity, 10/01/09    Relevance Score: 84%

Today in Bladder...keeping you current

Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09

Laparoscopic versus open radical cystectomy for the management of bladder cancer: Mid-term oncological outcome
International Journal of Urology, 12/04/09

XPC gene variants: a risk factor for recurrence of urothelial bladder carcinoma in patients on BCG immunotherapy
Journal of Cancer Research & Clinical Oncology, 12/04/09

Today in Clinical Pharmacology...keeping you current

Management of patients with advanced bladder cancer following major response to systemic chemotherapy
Expert Review of Anticancer Therapy, 12/04/09

Degarelix 240/80 mg: a new treatment option for patients with advanced prostate cancer
Expert Review of Anticancer Therapy, 12/04/09

Current status of chemotherapy in risk-adapted management for metastatic testicular germ cell cancer
Cancer Science, 12/04/09